EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Carnosine/histidine-containing dipeptide supplementation improves depression and quality of life: systematic review and meta-analysis of randomized controlled trials

Robel Hussen Kabthymer, Saeede Saadati, Mark Lee, Rohit Hariharan, Jack Feehan, Aya Mousa iD, Barbora de Courten iD

Nutrition Reviews · 2025

DOI: 10.1093/nutrit/nuae021 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrition Reviews, 2025. Verfasst von Robel Hussen Kabthymer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia. Hauptthemen laut MEDLINE: Carnosine, Depression, Dipeptides, Histidine. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University, National Health and Medical Research Council, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Mental ill-health is a common and growing issue, affecting 1 in 8 individuals or 970 million people worldwide in 2019. Histidine-containing dipeptides (HCDs) have been suggested to mitigate some aspects of mental ill-health, but a quantitative synthesis of the evidence is lacking. Therefore, a systematic review and meta-analysis of randomized controlled trials was conducted.

Objective

To summarize the evidence on the effects of HCDs on mental health outcomes. Data Source A systematic literature search was performed using electronic databases (Medline via Ovid, Embase via Ovid, Scopus, Google Scholar, and Cochrane) from inception to October, 2022. Data Extraction Two authors independently extracted data using a structured extraction format. Data Analysis Data analysis was performed using STATA version 17. Random-effects models were used, and heterogeneity was assessed using the I2 test. Quality appraisal was performed using the Cochrane risk-of-bias 2.0 tool and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.

Conclusion

5507 studies were identified, with 20 studies fulfilling the inclusion criteria. Eighteen studies comprising 776 participants were included in the meta-analysis. HCD supplementation (anserine/carnosine, l-carnosine, β-alanine) caused a significant reduction in depression scores measured with the Becks Depression Inventory (−0.79; 95% CI: −1.24, -0.35; moderate certainty on GRADE) when compared with placebo. An increase in quality-of-life scores measured with the 36-item Short-Form survey (SF-36) (0.65; 95% CI: 0.00, 1.30) and low certainty on GRADE in HCDs (anserine/carnosine, l-carnosine, β-alanine) when compared with placebo were found. However, the rest of the outcomes did not show a significant change between HCD supplementation and placebo. Although the number of studies included in the meta-analysis was modest, a significant mean reduction was observed in depression score as well as an increase in quality-of-life score for the HCD group when compared with placebo. Most of the studies included had small sample sizes with short follow-up periods and moderate to high risk of bias, highlighting the need for further, well-designed studies to improve the evidence base. Systematic Review Registration PROSPERO registration no. CRD42017075354.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarnosineDepressionDipeptidesHistidineQuality of LifeHumansDietary SupplementsRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

carnosinedepressionhistidine-containing dipeptidemeta-analysisquality of life

Substanzen

CarnosineDipeptidesHistidine

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Sciences, Monash University, Melbourne, Australia.
  • School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia.
  • Institute for Health and Sport, Victoria University, Melbourne, Australia.
  • Monash Centre for Health Research and Implementation (MCHRI), Monash University, Melbourne, Australia.

ORCID-Profile: Aya Mousa, Barbora de Courten

Förderung

  • Monash University
  • National Health and Medical Research Council
  • NHMRC

Zitieren

APA

Kabthymer, R. H., Saadati, S., Lee, M., Hariharan, R., Feehan, J., Mousa, A., & de Courten, B. (2025). Carnosine/histidine-containing dipeptide supplementation improves depression and quality of life: systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuae021

Vancouver

Kabthymer RH, Saadati S, Lee M, Hariharan R, Feehan J, Mousa A, et al. Carnosine/histidine-containing dipeptide supplementation improves depression and quality of life: systematic review and meta-analysis of randomized controlled trials. Nutrition Reviews. 2025. doi:10.1093/nutrit/nuae021

BibTeX
@article{Kabthymer2025,
  author = {Kabthymer, Robel Hussen and Saadati, Saeede and Lee, Mark and Hariharan, Rohit and Feehan, Jack and Mousa, Aya and de Courten, Barbora},
  title = {Carnosine/histidine-containing dipeptide supplementation improves depression and quality of life: systematic review and meta-analysis of randomized controlled trials},
  journal = {Nutrition Reviews},
  year = {2025},
  doi = {10.1093/nutrit/nuae021}
}
Kostenlos starten →